A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
Analytical methods for the determination of remdesivir as a promising antiviral candidate drug for the COVID-19 pandemic
2020
Drug Discoveries & Therapeutics
Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is undoubtedly the most challenging pandemic in the current century. A total of 73,953,702 confirmed cases of COVID-19 and 1,644,416 deaths were reported globally up to December 17, 2020. Therefore, in the absence of a safe and effective vaccine, it is urgent to identify a novel antiviral drug to effectively treat patients with COVID-19. On October 22, the U.S. Food and Drug
doi:10.5582/ddt.2020.03097
pmid:33390567
fatcat:rh5wbr6tenhitmaewdruwe5t4a